ZHAO Min, XU An-li, CHEN Hui-min, et al. Experimental Study of Yougui Wan on JAK/STATs Pathway in Kidney-yang Deficiency and Hyperlipidemia Rats[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(21): 108-112.
DOI:
ZHAO Min, XU An-li, CHEN Hui-min, et al. Experimental Study of Yougui Wan on JAK/STATs Pathway in Kidney-yang Deficiency and Hyperlipidemia Rats[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(21): 108-112. DOI: 10.13422/j.cnki.syfjx.2015210108.
Experimental Study of Yougui Wan on JAK/STATs Pathway in Kidney-yang Deficiency and Hyperlipidemia Rats
Objective: To establish kidney-yang deficiency and hyperlipidemia rat models through high dose of hydrocortisone injection
with intervention by Yougui Wan
observe the effects of Yougui Wan on janus activated kinase signaltransducer 2 (JAK2)
signal transducer and activator of transcription 3 (STAT3) and liver X receptor α (LXRα) protein and gene expression in model rats
and to study the relationship between JAK2/STAT3 signal transduction pathway and blood lipid abnormality of kidney-yang deficiency rats. Method: Sixty SD rats were divided into normal group
model group
Yougui Wan group (2.43 g·kg-1). Kidney-yang deficiency rat models were made using high dose hydrocortisone injections. Normal control rats were not modeled. The rats in model group were modeled and received normal saline. Rats in Yougui Wan group were modeled and received Yougui Wan suspension ig. Triglycerides (TG)
total cholesterol (TC)
low-density lipoprotein cholesterol (LDL-C)
and high density lipoprotein cholesterol (HDL-C) contents were detected. Immunohistochemitry was done to detect LXRα protein expression in liver tissues
and RT-PCR was used to detect the expressions of JAK2
STAT3 and LXRα in rat liver tissues. Result: Compared with the normal control group
the contents of TG
TC
LDL-C in serum of model group and Yougui Wan group rats were increased significantly (P<0.01)
HDL-C content was significantly decreased (P<0.01). Compared with the model group
the contents of TG
TC
LDL-C in serum of Yougui Wan group were decreased significantly (P<0.01)
and HDL-C content was significantly increased (P<0.01). Compared with normal control group
the expression of LXRα protein in kidney-yang deficiency rats of model group was significantly increased (P<0.05) in the liver
and JAK2
STAT3 and LXRα gene expressions were increased (P<0.05). Compared with the model group
the expression of LXRα protein in rat liver of Yougui Wan group was significantly decreased (P<0.05)
and JAK2
STAT3 and LXRα gene expressions were decreased (P<0.05). Conclusion: The kidney-yang deficiency and hyperlipidemia rat models made by hydrocortisone intramuscular injections may affect blood triglycerides and cholesterol metabolism through up-regulating JAK2
STAT3 and LXRα proteins and genes in pathways transduced by JAK2/STAT3 signals. Yougui Wan may reduce the content of lipid in model rats by inhibiting expression of related cytokines proteins and genes in pathways transduced by JAK2/STAT3 signals.
Clinical Efficacy of Zhuyuwan in Treatment of Hyperlipidemia with Syndrome of Phlegm Turbidity and Obstruction
Zhuyuwan in Treatment of Hyperlipidemia Complicated with Carotid Atherosclerosis: A Randomized Controlled Trial
Mechanism of Wendantang in Intervention of ApoE-/- Hyperlipidemic Mice Based on Liver Metabolomics
Effect of Zuogui Wan and Yougui Wan on Mitochondrial Biogenesis in BMSCs Through PGC-1α/PPARγ
Polygonati Odorati Rhizoma Polysaccharides Ameliorate Hyperlipidemia in Mice by Regulating Gut Microbiota
Related Author
YANG Lele
LUO Danmei
CHEN Jiao
ZHANG Xiaobo
SONG Wei
ZHU Wenyu
ZHOU Xin
LI Xueping
Related Institution
Chengdu University of TCM
Hospital of Chengdu University of Traditional Chinese Medicine (TCM)
Hospital of Chengdu University of TCM
Chengdu University of Traditional Chinese Medicine(TCM)
Research Center for Differentiation and Development of Traditional Chinese Medicine (TCM) Basic Theory/Jiangxi Province Key Laboratory of Biological Etiologies of TCM/First-Level Discipline Platform of Chinese and Western Integrative Medicine/Experimental Animal and Scientific Technology Center of Jiangxi University of Chinese Medicine/School of Pharmacy, Jiangxi University of Chinese Medicine